Teva Reports Positive Data from Anti-TL1A Antibody for Inflammatory Bowel Diseases

TEV-’574 has shown potential as a treatment for inflammatory bowel diseases such as ulcerative colitis and Crohn disease.

Source link
#Teva #Reports #Positive #Data #AntiTL1A #Antibody #Inflammatory #Bowel #Diseases